Last reviewed · How we verify

NCT06761859

Aromatherapy Inhalation in Psychiatric Nurses

Completed NA Last updated 7 February 2025
What this trial tests

NA trial testing Aromatherapy Inhalation in Psychiatric Nurses in Aromatherapy in 66 participants. Completed in 5 February 2025.

Timeline
1 January 2025
Primary endpoint
31 January 2025
5 February 2025

Quick facts

Lead sponsorSERDAR TÜRKYILMAZ
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment66
Start date1 January 2025
Primary completion31 January 2025
Estimated completion5 February 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

SERDAR TÜRKYILMAZ

Who can join

Adults 18 to 65, any sex, with Aromatherapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study will be conducted with a total of 66 psychiatric nurses who meet the inclusion and exclusion criteria and are working at Ankara Etlik City Hospital Psychiatry Clinic between January 1, 2025 and March 31, 2025.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Aromatherapy

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06761859.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing